{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:10:37Z","timestamp":1788862237022,"version":"build-2803163510"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA113275"],"award-info":[{"award-number":["T32CA113275"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA203995"],"award-info":[{"award-number":["R01CA203995"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA293071"],"award-info":[{"award-number":["R01CA293071"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA25153905"],"award-info":[{"award-number":["R01CA25153905"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation for Barnes-Jewish Hospital, Cancer Frontier Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lung cancer is currently the leading cause of cancer-related deaths worldwide. Approximately 85% of lung cancer patients have non-small cell lung cancer (NSCLC), and &amp;gt;50% of these patients present with metastasis at their initial diagnosis. Despite advances in our understanding of lung cancer oncogenesis, the mechanism by which lung cancer becomes aggressive and leads to patient death is still poorly characterized. We found that long noncoding RNA RNA-associated with metastasis 11 (RAMS11) (LINC01564) is significantly upregulated in lung cancer patients compared to healthy patients. Here, we demonstrate that RAMS11 is critical for NSCLC tumor progression by regulating expression of NOTCH3, a key driver of tumorigenic potential. Mechanistically, RAMS11 is essential for NRF2 chromatin binding and the associated deposition of the active enhancer mark, H3K27ac, at the NOTCH3 enhancer region. Functional analysis revealed RAMS11\u2013NRF2-dependent activation of NOTCH3 signaling enforces a tumor-initiating capacity, characterized by enhanced self-renewal capabilities and tumor initiation ability, thereby supporting malignant proliferation. Moreover, disruption of\u00a0RAMS11 signaling markedly suppressed tumorigenic growth and sensitized NSCLC cells to cisplatin-induced apoptosis, uncovering a potential therapeutic vulnerability to more effectively target NSCLC patients. Collectively, these findings reveal a previously unknown role of RAMS11 in NSCLC progression and chemotherapy resistance.<\/jats:p>","DOI":"10.1093\/narcan\/zcag020","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T11:25:19Z","timestamp":1786879519000},"source":"Crossref","is-referenced-by-count":0,"title":["LncRNA\n                    <i>RAMS11<\/i>\n                    -dependent\n                    <i>NOTCH3<\/i>\n                    activation drives tumor progression in non-small cell lung cancer"],"prefix":"10.1093","volume":"8","author":[{"given":"Gejae G","family":"Jeffers","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Washington University School of Medicine , St. Louis, MO, 63110,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesol","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Washington University School of Medicine , St. Louis, MO, 63110,","place":["United States"]},{"name":"Alvin J. Siteman Cancer Center, Washington University School of Medicine , St. Louis, MO, 63110,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M","family":"White","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Washington University School of Medicine , St. Louis, MO, 63110,","place":["United States"]},{"name":"Alvin J. Siteman Cancer Center, Washington University School of Medicine , St. Louis, MO, 63110,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Washington University School of Medicine , St. Louis, MO, 63110,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily B","family":"Rozycki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Washington University School of Medicine , St. Louis, MO, 63110,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Ly","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Washington University School of Medicine , St. Louis, MO, 63110,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9035-603X","authenticated-orcid":false,"given":"Christopher\u00a0A","family":"Maher","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Washington University School of Medicine , St. Louis, MO, 63110,","place":["United States"]},{"name":"Alvin J. Siteman Cancer Center, Washington University School of Medicine , St. Louis, MO, 63110,","place":["United States"]},{"name":"Department of Biomedical Engineering, Washington University School of Medicine , St. Louis, MO, 63110,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"2026090805170063700_B1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"2026090805170063700_B2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"2026090805170063700_B3","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.21037\/jtd-20-3075","article-title":"Prognostic value of symptoms at lung cancer diagnosis: a three-year observational study","volume":"13","author":"Polanco","year":"2021","journal-title":"J Thorac Dis"},{"key":"2026090805170063700_B4","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"2026090805170063700_B5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nchembio.1120","article-title":"Peptidomic discovery of short open reading frame\u2013encoded peptides in human cells","volume":"9","author":"Slavoff","year":"2013","journal-title":"Nat Chem Biol"},{"key":"2026090805170063700_B6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1158\/2159-8290.CD-11-0209","article-title":"The emergence of lncRNAs in cancer biology","volume":"1","author":"Prensner","year":"2011","journal-title":"Cancer Discov"},{"key":"2026090805170063700_B7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ccr.2014.07.009","article-title":"A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer","volume":"26","author":"Hu","year":"2014","journal-title":"Cancer Cell"},{"key":"2026090805170063700_B8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.ccell.2018.03.006","article-title":"lncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer","volume":"33","author":"Wang","year":"2018","journal-title":"Cancer Cell"},{"key":"2026090805170063700_B9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","article-title":"Long noncoding RNAs in cancer pathways","volume":"29","author":"Schmitt","year":"2016","journal-title":"Cancer Cell"},{"key":"2026090805170063700_B10","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nm.3981","article-title":"The emerging role of lncRNAs in cancer","volume":"21","author":"Huarte","year":"2015","journal-title":"Nat Med"},{"key":"2026090805170063700_B11","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1038\/s41467-020-15547-8","article-title":"Long non-coding RNA RAMS11 promotes metastatic colorectal cancer progression","volume":"11","author":"Silva-Fisher","year":"2020","journal-title":"Nat Commun"},{"key":"2026090805170063700_B12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13059-014-0429-8","article-title":"Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancer","volume":"15","author":"White","year":"2014","journal-title":"Genome Biol"},{"key":"2026090805170063700_B13","doi-asserted-by":"publisher","first-page":"e03521","DOI":"10.1016\/j.heliyon.2020.e03521","article-title":"Long non-coding RNA LCAL62\/LINC00261 is associated with lung adenocarcinoma prognosis","volume":"6","author":"Dang","year":"2020","journal-title":"Heliyon"},{"key":"2026090805170063700_B14","doi-asserted-by":"publisher","first-page":"6768","DOI":"10.1002\/jcp.26530","article-title":"H19 promotes non-small-cell lung cancer (NSCLC) development through STAT3 signaling via sponging miR-17","volume":"233","author":"Huang","year":"2018","journal-title":"J Cell Physiol"},{"key":"2026090805170063700_B15","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/0008-5472.CAN-12-2850","article-title":"The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells","volume":"73","author":"Gutschner","year":"2013","journal-title":"Cancer Res"},{"key":"2026090805170063700_B16","doi-asserted-by":"publisher","first-page":"8031","DOI":"10.1038\/sj.onc.1206928","article-title":"MALAT-1, a novel noncoding RNA, and thymosin \u03b24 predict metastasis and survival in early-stage non-small cell lung cancer","volume":"22","author":"Ji","year":"2003","journal-title":"Oncogene"},{"key":"2026090805170063700_B17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fgene.2017.00208","article-title":"Identification of minimal p53 promoter region regulated by MALAT1 in human","volume":"8","author":"Tano","year":"2017","journal-title":"Front Genet"},{"key":"2026090805170063700_B18","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1080\/15476286.2015.1038012","article-title":"Pan-cancer transcriptome analysis reveals long noncoding RNAs with conserved function","volume":"12","author":"Cabanski","year":"2015","journal-title":"RNA Biol"},{"key":"2026090805170063700_B19","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1038\/s41388-021-01749-x","article-title":"Energy stress-induced linc01564 activates the serine synthesis pathway and facilitates hepatocellular carcinogenesis","volume":"40","author":"Zhang","year":"2021","journal-title":"Oncogene"},{"key":"2026090805170063700_B20","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1007\/s12035-022-02736-3","article-title":"LINC01564 promotes the TMZ resistance of glioma cells by upregulating NFE2L2 expression to inhibit ferroptosis","volume":"59","author":"Luo","year":"2022","journal-title":"Mol Neurobiol"},{"key":"2026090805170063700_B21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"2026090805170063700_B22","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1371\/journal.pmed.0030420","article-title":"Dysfunctional KEAP1\u2013NRF2 interaction in non-small-cell lung cancer","volume":"3","author":"Singh","year":"2006","journal-title":"PLoS Med"},{"key":"2026090805170063700_B23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","author":"The Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"2026090805170063700_B24","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature11404","article-title":"Comprehensive genomic characterization of squamous cell lung cancers","volume":"489","author":"The Cancer Genome Atlas Research Network","year":"2012","journal-title":"Nature"},{"key":"2026090805170063700_B25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2026090805170063700_B26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1158\/2159-8290.CD-21-0922","article-title":"NRF2: kEAPing tumors protected","volume":"12","author":"Pillai","year":"2022","journal-title":"Cancer Discov"},{"key":"2026090805170063700_B27","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol Rev"},{"key":"2026090805170063700_B28","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1158\/1078-0432.CCR-17-1841","article-title":"Effects of co-occurring genomic alterations on outcomes in patients with KRAS -mutant non\u2013small cell lung cancer","volume":"24","author":"Arbour","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2026090805170063700_B29","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1158\/1078-0432.CCR-08-2822","article-title":"Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer","volume":"15","author":"Homma","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2026090805170063700_B30","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1158\/2159-8290.CD-20-0282","article-title":"KEAP1\/NFE2L2 mutations predict lung cancer radiation resistance that can be targeted by glutaminase inhibition","volume":"10","author":"Binkley","year":"2020","journal-title":"Cancer Discov"},{"key":"2026090805170063700_B31","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/carcin\/bgn095","article-title":"Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2","volume":"29","author":"Wang","year":"2008","journal-title":"Carcinogenesis"},{"key":"2026090805170063700_B32","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1038\/onc.2017.236","article-title":"IL-11 contribution to tumorigenesis in an NRF2 addiction cancer model","volume":"36","author":"Kitamura","year":"2017","journal-title":"Oncogene"},{"key":"2026090805170063700_B33","doi-asserted-by":"publisher","first-page":"16111","DOI":"10.1074\/jbc.M111.322107","article-title":"Reciprocal regulation of syndecan-2 and notch signaling in vascular smooth muscle cells","volume":"287","author":"Zhao","year":"2012","journal-title":"J Biol Chem"},{"key":"2026090805170063700_B34","doi-asserted-by":"publisher","first-page":"5911","DOI":"10.1038\/s41467-020-19593-0","article-title":"Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers","volume":"11","author":"Okazaki","year":"2020","journal-title":"Nat Commun"},{"key":"2026090805170063700_B35","doi-asserted-by":"publisher","first-page":"10228","DOI":"10.1093\/nar\/gks827","article-title":"Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks","volume":"40","author":"Hirotsu","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"2026090805170063700_B36","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","article-title":"Molecular mechanisms of long noncoding RNAs","volume":"43","author":"Wang","year":"2011","journal-title":"Mol Cell"},{"key":"2026090805170063700_B37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-biochem-051410-092902","article-title":"Genome regulation by long noncoding RNAs","volume":"81","author":"Rinn","year":"2012","journal-title":"Annu Rev Biochem"},{"key":"2026090805170063700_B38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","article-title":"Evolution of the cancer stem cell model","volume":"14","author":"Kreso","year":"2014","journal-title":"Cell Stem Cell"},{"key":"2026090805170063700_B39","doi-asserted-by":"publisher","first-page":"9937","DOI":"10.1158\/0008-5472.CAN-10-0881","article-title":"Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling","volume":"70","author":"Sullivan","year":"2010","journal-title":"Cancer Res"},{"key":"2026090805170063700_B40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ccr.2013.05.021","article-title":"A rare population of CD24+ITGB4+Notchhi cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal","volume":"24","author":"Zheng","year":"2013","journal-title":"Cancer Cell"},{"key":"2026090805170063700_B41","doi-asserted-by":"publisher","first-page":"34362","DOI":"10.18632\/oncotarget.16156","article-title":"Notch3 overexpression enhances progression and chemoresistance of urothelial carcinoma","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"2026090805170063700_B42","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.2353\/ajpath.2010.100316","article-title":"Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin","volume":"177","author":"Park","year":"2010","journal-title":"Am J Pathol"},{"key":"2026090805170063700_B43","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1158\/1078-0432.CCR-12-0370","article-title":"Notch pathway activity identifies cells with cancer stem cell\u2013like properties and correlates with worse survival in lung adenocarcinoma","volume":"19","author":"Hassan","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2026090805170063700_B44","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","article-title":"Identification and expansion of the tumorigenic lung cancer stem cell population","volume":"15","author":"Eramo","year":"2008","journal-title":"Cell Death Differ"},{"key":"2026090805170063700_B45","doi-asserted-by":"publisher","first-page":"e35040","DOI":"10.1371\/journal.pone.0035040","article-title":"Matrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential","volume":"7","author":"Justilien","year":"2012","journal-title":"PLoS One"},{"key":"2026090805170063700_B46","doi-asserted-by":"publisher","first-page":"694141","DOI":"10.3389\/fmolb.2021.694141","article-title":"The role of Notch3 signaling in cancer stemness and chemoresistance: molecular mechanisms and targeting strategies","volume":"8","author":"Xiu","year":"2021","journal-title":"Front Mol Biosci"},{"key":"2026090805170063700_B47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.14348\/molcells.2023.2196","article-title":"Emerging role of NRF2 signaling in cancer stem cell phenotype","volume":"46","author":"Hallis","year":"2023","journal-title":"Mol Cells"},{"key":"2026090805170063700_B48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.pharmthera.2016.02.008","article-title":"Cancer stem cells and chemoresistance: the smartest survives the raid","volume":"160","author":"Zhao","year":"2016","journal-title":"Pharmacol Ther"},{"key":"2026090805170063700_B49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ctrv.2016.01.003","article-title":"Cisplatin in the modern era: the backbone of first-line chemotherapy for non-small cell lung cancer","volume":"44","author":"Fennell","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"2026090805170063700_B50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4137\/CMO.S6252","article-title":"Gemcitabine: efficacy in the treatment of advanced stage nonsquamous non-small cell lung cancer","volume":"5","author":"Hayashi","year":"2011","journal-title":"Clin Med Insights Oncol"},{"key":"2026090805170063700_B51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13045-016-0311-0","article-title":"Modification of platinum sensitivity by KEAP1\/NRF2 signals in non-small cell lung cancer","volume":"9","author":"Tian","year":"2016","journal-title":"J Hematol Oncol"},{"key":"2026090805170063700_B52","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cmet.2023.01.012","article-title":"NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer","volume":"35","author":"Weiss-Sadan","year":"2023","journal-title":"Cell Metab"},{"key":"2026090805170063700_B53","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ccell.2016.02.012","article-title":"Protein kinase c\u03b9 drives a NOTCH3-dependent stem-like phenotype in mutant KRAS lung adenocarcinoma","volume":"29","author":"Ali","year":"2016","journal-title":"Cancer Cell"},{"key":"2026090805170063700_B54","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41392-020-00430-1","article-title":"Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents","volume":"6","author":"Zhou","year":"2021","journal-title":"Sig Transduct Target Ther"},{"key":"2026090805170063700_B55","doi-asserted-by":"publisher","first-page":"e2746","DOI":"10.1038\/cddis.2016.409","article-title":"Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1\/HDAC activity","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis"},{"key":"2026090805170063700_B56","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s43556-025-00352-w","article-title":"Drug resistance in cancer: molecular mechanisms and emerging treatment strategies","volume":"6","author":"Li","year":"2025","journal-title":"Mol Biomed"},{"key":"2026090805170063700_B57","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","article-title":"Hallmarks of cancer stemness","volume":"31","author":"Loh","year":"2024","journal-title":"Cell Stem Cell"}],"container-title":["NAR Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/narcancer\/article-pdf\/8\/3\/zcag020\/70989777\/zcag020.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/narcancer\/article-pdf\/8\/3\/zcag020\/70989777\/zcag020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T09:17:08Z","timestamp":1788859028000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/narcancer\/article\/doi\/10.1093\/narcan\/zcag020\/8787813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7,27]]}},"URL":"https:\/\/doi.org\/10.1093\/narcan\/zcag020","relation":{},"ISSN":["2632-8674"],"issn-type":[{"value":"2632-8674","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,7,27]]},"article-number":"zcag020"}}